Oxford Biomedica (OXB) News Today GBX 347.78 +4.28 (+1.25%) As of 06:43 AM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock OXB Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Oxford Biomedica (LON:OXB) Shares Cross Below Two Hundred Day Moving Average - Here's What HappenedJuly 3, 2025 | marketbeat.comInsider Spends UK£37k Buying More Shares In Oxford BiomedicaJune 25, 2025 | finance.yahoo.comOxford Biomedica (LON:OXB) Share Price Passes Below 200-Day Moving Average - Time to Sell?June 25, 2025 | marketbeat.comOxford Biomedica completes acquisition of remaining stake in U.S. subsidiaryJune 24, 2025 | finance.yahoo.comHeather Preston Acquires 11,389 Shares of Oxford Biomedica plc (LON:OXB) StockJune 18, 2025 | insidertrades.comHeather Preston Buys 11,389 Shares of Oxford Biomedica plc (LON:OXB) StockJune 17, 2025 | marketbeat.comOxford Biomedica (LON:OXB) Stock Price Crosses Below Two Hundred Day Moving Average - Here's What HappenedJune 10, 2025 | marketbeat.comOxford Biomedica (LON:OXB) Stock Price Crosses Below 200 Day Moving Average - Time to Sell?May 25, 2025 | marketbeat.comOxford Biomedica announces executive share option grantsMay 17, 2025 | uk.investing.comOxford Biomedica (LON:OXB) Stock Price Crosses Below 200-Day Moving Average - Time to Sell?May 17, 2025 | marketbeat.comOxford Biomedica (LON:OXB) Stock Price Passes Below 200-Day Moving Average - Should You Sell?May 9, 2025 | marketbeat.comOxford BioMedica PLC OXBMay 7, 2025 | morningstar.comMOxford Biomedica insider completes share transactionMay 2, 2025 | uk.investing.comOxford Biomedica (LON:OXB) Share Price Crosses Below Two Hundred Day Moving Average - What's Next?April 30, 2025 | marketbeat.comOxford Biomedica (LON:OXB) Shares Up 12.1% - Here's What HappenedApril 12, 2025 | marketbeat.comOxford Biomedica (LON:OXB) Posts Quarterly Earnings ResultsApril 11, 2025 | marketbeat.comOxford Biomedica reports FY24 EPS (GPB 41.75) vs. (GPB 163.11) last yearApril 9, 2025 | msn.comOxford Biomedica falls on lower EBITDA outlook despite strong revenue guideApril 9, 2025 | investing.comViroCell Biologics Appoints Viral Vector Expert as Special AdvisorMarch 28, 2025 | finance.yahoo.comOXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' categoryMarch 21, 2025 | markets.businessinsider.comOxford Biomedica (LON:OXB) Stock Price Passes Below 200-Day Moving Average - Here's WhyMarch 11, 2025 | marketbeat.comOxford Biomedica backs novel cystic fibrosis gene therapy trialFebruary 21, 2025 | investing.comBoehringer and partners commence gene therapy trial for cystic fibrosisFebruary 21, 2025 | msn.comBoehringer Ingelheim and partners start clinical development of a first-in-class, inhaled gene therapy for people with cystic fibrosisFebruary 20, 2025 | markets.businessinsider.comNovel inhalable gene therapy trialed for people with cystic fibrosisFebruary 20, 2025 | msn.comSMALL-CAP WINNERS & LOSERS: Wilmington half-year profit fallsFebruary 17, 2025 | lse.co.ukOxford BioMedica shares fall as revenue to stay below 2022 levelFebruary 17, 2025 | lse.co.ukOxford Biomedica Share Chat (OXB)February 14, 2025 | lse.co.ukOxford Biomedica (LON:OXB) Stock Passes Above 200-Day Moving Average - Should You Sell?February 13, 2025 | marketbeat.comOxford Biomedica (LON:OXB) Share Price Crosses Above 200-Day Moving Average - Here's WhyFebruary 5, 2025 | marketbeat.comOxford Biomedica (LON:OXB) Reaches New 52-Week High - Time to Buy?January 28, 2025 | marketbeat.comOxford Biomedica (LON:OXB) Stock Price Crosses Above Fifty Day Moving Average - Should You Sell?January 7, 2025 | marketbeat.comOxford Biomedica (LON:OXB) Share Price Crosses Above Fifty Day Moving Average - What's Next?December 28, 2024 | marketbeat.comOxford Biomedica (LON:OXB) Stock Price Up 0.1% - Here's What HappenedDecember 12, 2024 | marketbeat.comOxford Biomedica Strengthens Board with Key AppointmentNovember 18, 2024 | msn.comOxford Biomedica (LON:OXB) Shares Cross Above 200-Day Moving Average - Should You Sell?November 2, 2024 | marketbeat.comOxford Biomedica Announces Total Voting Rights UpdateNovember 1, 2024 | markets.businessinsider.comOxford BioMedica Sees Shift in Voting RightsOctober 31, 2024 | markets.businessinsider.comOxford Biomedica (LON:OXB) Hits New 1-Year High - Should You Buy?October 25, 2024 | marketbeat.comThis skyrocketing growth stock is up 100% this year! Is it too late to buy?October 23, 2024 | msn.comOxford Biomedica (LON:OXB) Sets New 52-Week High - Still a Buy?October 16, 2024 | marketbeat.comOxford BioMedica PLC (OXBDF) (Q2 2024) Earnings Call Transcript Highlights: Strong Revenue ...September 24, 2024 | finance.yahoo.comOxford Biomedica plc (OXBDF) Q2 2024 Earnings Call TranscriptSeptember 23, 2024 | seekingalpha.comPositive Signs As Multiple Insiders Buy Oxford Biomedica StockSeptember 16, 2024 | finance.yahoo.comOxford Biomedica to host a free webinar showcasing its AAV expertiseAugust 27, 2024 | uk.finance.yahoo.comOxford Biomedica Regulatory NewsAugust 12, 2024 | lse.co.ukOxford BioMedica plc: Oxford Biomedica - Half Year Trading Update and Notice of Interim ResultsAugust 8, 2024 | finanznachrichten.deOxford BioMedica plc: Oxford Biomedica announces CFO transitionJuly 19, 2024 | finanznachrichten.deOxford Biomedica (LON:OXB) investors are sitting on a loss of 71% if they invested three years agoMay 28, 2024 | finance.yahoo.comOxford Biomedica (LON:OXB) investors are sitting on a loss of 71% if they invested three years agoMay 28, 2024 | finance.yahoo.com Get Oxford Biomedica News Delivered to You Automatically Sign up to receive the latest news and ratings for OXB and its competitors with MarketBeat's FREE daily newsletter. Email Address OXB Media Mentions By Week OXB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OXB News Sentiment▼1.050.57▲Average Medical News Sentiment OXB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OXB Articles This Week▼10▲OXB Articles Average Week Get Oxford Biomedica News Delivered to You Automatically Sign up to receive the latest news and ratings for OXB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Genus News Oxford Nanopore Technologies News PureTech Health News Faron Pharmaceuticals Oy News Bioventix News 4basebio News Avacta Group News Ondine Biomedical News Scancell News hVIVO News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:OXB) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Biomedica plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford Biomedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
